Sub menu

 

 

COVID-19 vaccine: Janssen

The Therapeutic Goods Administration (TGA) granted provisional approval to Janssen-Cilag Pty Ltd (known as Johnson & Johnson overseas) for its COVID-19 vaccine Janssen, making it the third COVID-19 vaccine to receive regulatory approval in Australia.

Published

Voluntary cancellation of COVID-19 vaccine Janssen

On 28 August 2023, Janssen-Cilag Pty Ltd voluntarily cancelled COVID-19 VACCINE JANSSEN from the Australian Register of Therapeutic Goods (ARTG).

The viral vector vaccine was provisionally approved by the TGA on 25 June 2021; however, the vaccine was never supplied in Australia.

Cancellation of this vaccine from the ARTG was a business decision of the company, due to no current or anticipated future demand of the vaccine, and follows similar business decisions made overseas.

Featured in

Related content